Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Clinical trial NCT06493552 · RECRUITING

Trial details

NCT number: NCT06493552
Sponsor: Vasgene Therapeutics, Inc
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma Metastatic Urothelial Carcinoma

Start date: 2025-03-15
Primary completion: 2029-09-01
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.